National Center for Safety Evaluation of Drugs

The National Center for Safety Evaluation of Drugs (NCSED) is a premier Chinese contract research organization (CRO) and a specialized division of the National Institutes for Food and Drug Control (NIFDC). As a leading GLP-compliant institution, NCSED provides comprehensive pre-clinical safety assessment services for a wide array of therapeutic modalities, including small molecules, biologics, and advanced cell and gene therapies. The center is instrumental in the Chinese regulatory framework, conducting pivotal toxicology, safety pharmacology, and pharmacokinetic studies that support IND and NDA filings with the National Medical Products Administration (NMPA). NCSED serves both domestic and international pharmaceutical clients, leveraging its state-of-the-art facilities in Beijing to ensure drug safety and public health.